Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
Completed
Conditions studied: Prostate Cancer
In brief
This clinical utility study is based on a review of real but de-identified and randomized patient cases and aims to evaluate radiation oncologist's treatment recommendations before and after reviewing the results provided by the Decipher test. The primary intent is to help guide development and design of future clinical utility studies for Decipher.
Key facts
- Study ID
- NCT02034812
- Run by
- GenomeDx Biosciences Corp
- People needed
- 25
- Starts
- 2013-07-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2016-02-29
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.